Mountain Valley MD Holdings Inc. (CSE:MVMD)

Revenue by Segment

Financials in millions CAD. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019
Research and Development of Its Delivery, Solubility, and Adjuvant Technologies	49.00K	60.00K	-	110.00K	-
Research and Development of Its Delivery, Solubility, and Adjuvant Technologies Growth	-18.33%	-	-	-	-
Total	49.00K	60.00K	-	110.00K	-
Total Growth	-18.33%	-	-	-	-

Revenue by Geography

Financials in millions CAD. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019
Canada	49.00K	60.00K	-	110.00K	-
Canada Growth	-18.33%	-	-	-	-
Total	49.00K	60.00K	-	110.00K	-
Total Growth	-18.33%	-	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 21, 2026

Data Sources Report a data error